AstraZeneca breast cancer drug fails trial but Citi keeps 'buy' rating

- Citi: 3 events in the last 90 days
- Previous: 6 days earlier · U.S. stocks usually stumble after Fed hikes, but these markets tend to climb, says Citi
What happened
Summary assembled by rule from the sources below